Skip to content

Mental attitude of patients and therapists towards the pharmaceutical therapy of alcohol dependence

Mental attitude of patients and therapists towards the pharmaceutical therapy of alcohol dependence

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00013881
Enrollment
300
Registered
2018-04-26
Start date
2018-06-15
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F10.2

Interventions

Group 1: Aim of this study is to identify factors on behalf of 300 alcohol dependent patients (ICD10 F10.2) and addiction-therapists inhibiting recommendation, administration and usage (i.e. implement

Sponsors

LVR-Klinikum Essen
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Existing alcohol-dependency (ICD10 F10.2), no acute episode of psychotic disorder or intoxication, minimum age of 18 years, sufficient comprehension of the German language in order to fully understand questions asked.

Exclusion criteria

Exclusion criteria: No existing alcohol-dependency (ICD10: F10.2), acute episode of psychotic disorder, intoxication, younger than 18 years, insufficient comprehension of the German language hence not capable of fully understanding questions asked.

Design outcomes

Primary

MeasureTime frame
Primary Aim: To identify factors on behalf of alcohol dependent patients and addiction-therapists inhibiting recommendation, administration and usage of Anti-Craving drugs. Patient questionning: Personal systemic clinical interview of out- and inpatient alcohol-dependant patients. The patient´s questionnaire includes questions on sociodemographic data, somatic and psychiatric illness, substance abuse and addiction, current medication and knowledge on and experience with Anti-Craving drugs. Therapist questionning: The therapist´s questionnaire includes questions on sociodemographic data, work experience in the therapy of substance dependence, knowledge of Anti-Craving drugs and their attitude towards these substances. Answers to the questionnaire are recorded qualitativley and quantitatvely. The patients´questioning is planned to start in July 2018, the therapists´questioning in September 2018

Countries

Germany

Contacts

Public ContactJulian Wellensiek

LVR-Klinik Bonn

julian.wellensiek@lvr.de02285517355

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026